Skip to main content

Table 1 Characteristics of included studies

From: Comparison of the quadriceps-sparing and subvastus approaches versus the standard parapatellar approach in total knee arthroplasty: a meta-analysis of randomized controlled trials

Study-year

Country

Group

Patients (male/female)

Total TKA

Age

BMI

Follow-up

Results favoring

Chiang 2012

China

QS

30 (3/27)

38

69.7 ± 5.3

28.6 ± 3.8

2 years

MP

SP

30 (3/27)

37

69.8 ± 5.4

29.6 ± 3.5

Karpman 2009

America

QS

20 (8/12)

20

73 ± 7.4

28 ± 4.4

6 months

QS

SP

19 (9/10)

19

73 ± 5.1

29 ± 4.6

Kim 2007

Korea

QS

120 (27/93)

120

65.4 (43–88)

28.1 (19–36)

2 years

MP

SP

120 (27/93)

120

Lin 2009

China

QS

30 (3/27)

40

69.6 (57–78)

28.1 (20.1–36.9)

2 month

N.S

SP

30 (3/27)

40

70.2 (56–82)

29.0 (20.1–36.9)

Lin 2013

China

QS

35 (5/30)

35

67.7 ± 5

26.3 ± 2.5

2 years

QS

SP

35 (5/30)

35

68.5 ± 5.5

25.9 ± 2.6

Matsumoto 2011

Japan

QS

25 (0/25)

25

73.8 ± 1.7

Not reported

1 week

QS

SP

25 (0/25)

25

73.7 ± 1.4

Not reported

Shen 2007

China

QS

26 (−/−)

26

Not reported

Not reported

12 years

QS

SP

33 (−/−)

33

Not reported

Not reported

Tasker 2013

United Kingdom

QS

46 (17/29)

46

67.3 ± 8.4

Not reported

2 years

QS

SP

46 (17/29)

46

68.2 ± 7.5

Not reported

Xu 2013

China

QS

26 (7/19)

35

63.5 ± 8.7

25.2 ± 3.4

3 months

QS

SP

29 (11/18)

35

64.2 ± 9.3

25.2 ± 2.3

Roysam 2001

United Kingdom

SV

46 (25/21)

46

70.2

Not reported

3 months

SV

SP

43 (22/21)

43

69.8

Not reported

Weinhardt 2004

German

SV

26 (19/7)

26

69.7 ± 9.1

Not reported

13 days

N.S

SP

26 (14/12)

26

73.7 ± 6.8

Not reported

Bridgman 2009

United Kingdom

SV

116 (60/56)

116

70.1 ± 8.0

Not reported

1 year

SV

SP

115 (59/56)

115

70.9 ± 8.1

Not reported

Sastre 2009

Spain

SV

56 (not reported)

56

NR

Not reported

1 year

SV

SP

48 (not reported)

48

Not reported

Not reported

Pan 2010

China

SV

35 (11/24)

35

62.5 (54–70)

24.8 (19.5–28.6)

18 months

N.S

SP

33 (9/24)

33

63.2 (50–75)

24.6 (19.4–28.2)

Varela-Egocheaga

Spain

SV

50 (14/36)

50

68.02 ± 8.14

30.97 ± 5.25

3 years

SV

SP

50 (13/37)

50

70.64 ± 7.88

30.62 ± 3.42

Van Hemert 2010

Netherlands

SV

20 (6/14)

20

70.3 ± 11.8

29.2 ± 5.5

3 months

N.S

SP

20 (7/13)

20

70.9 ± 7.1

30.3 ± 5.9

Varnell 2011

Italy

SV

18 (11/7)

20

71 ± 6

30.96 ± 6.16

6 months

MP

SP

15 (5/10)

18

70 ± 7

28.15 ± 4.2

Wegrzyn 2013

USA

SV

18 (4/14)

18

71 ± 6

30.96 ± 6.16

2 months

N.S

SP

18 (4/14)

18

70 ± 7

28.15 ± 4.2

Jain 2013

India

SV

50 (12/38)

50

67 ± 8

30 ± 6

2 weeks

SV

SP

50 (12/38)

50

64 ± 7

31 ± 4

  1. BMI body mass index, SV subvastus, SP standard parapatellar, QS quadriceps-sparing, N.S not significant